A medical worker fills a syringe with a dose of the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine as Japan launches its inoculation campaign, at Tokyo Medical Center in Tokyo, Japan February 17, 2021. Behrouz Mehri/Pool via REUTERS/File Photo
Japan's government may approve the use of coronavirus vaccines developed by AstraZeneca PLC (AZN.L) and Moderna Inc (MRNA.O) as early as May 20, the Nikkei reported on Friday.
Health ministry officials plan to hold a meeting around that date to discuss approval, the financial daily reported.
The only vaccine for the novel coronavirus to have received Japanese approval so far is that developed by Pfizer Inc (PFE.N) and BioNTech SE (22UAy.DE).
Approvals for other vaccines are widely expected to come later this month, though no specific dates have been announced.
Prime Minister Yoshihide Suga has pledged to have enough vaccine doses for the country's 126 million people by June, before the July 23 start of the Tokyo Olympic Games.
Our Standards: The Thomson Reuters Trust Principles.
"may" - Google News
May 07, 2021 at 07:57AM
https://ift.tt/3o6WKnn
Japan may approve AstraZeneca, Moderna vaccines as early as May 20 -Nikkei - Reuters
"may" - Google News
https://ift.tt/3foH8qu
https://ift.tt/2zNW3tO
Bagikan Berita Ini
0 Response to "Japan may approve AstraZeneca, Moderna vaccines as early as May 20 -Nikkei - Reuters"
Post a Comment